Novel inhibitors of β-ketoacyl-ACP reductase from Escherichia coli

Chemico-Biological Interactions

Volumn 178, Issue 1-3, 2009, Pages 310-316

  Kristan, Katja ^a   Bratkovič, Tomaž ^a,b   Sova, Matej ^b   Gobec, Stanislav ^b   Preželj, Andrej ^a   Urleb, Uroš ^a  

^a Lek dd   (Slovenia)

^b UNIVERSITY OF LJUBLJANA   (Slovenia)

Author keywords

Ketoacyl ACP reductase; Cinnamic acid derivatives; FabG; Phage display

Indexed keywords

2 NITROPHENYLCINNAMATE; 3 OXOACYL ACYL CARRIER PROTEIN REDUCTASE; 3 PHENOXYBENZYL 3 (BENZO[D][1,3]DIOXOL 5 YL)ACRYLATE; 4 CYANOPHENYL 3 (BENZO[D][1,3]DIOXOL 5 YL)ACRYLATE; BENZYL 3 (BENZO[D][1,3]DIOXOL 5 YL)ACRYLATE; CINNAMIC ACID DERIVATIVE; ESCHERICHIA COLI PROTEIN; OXIDOREDUCTASE INHIBITOR; PHENYL 3 (BENZO[D][1,3]DIOXOL 5 YL)ACRYLATE; UNCLASSIFIED DRUG;

ARTICLE; DRUG DESIGN; DRUG SCREENING; ENZYME ACTIVE SITE; ENZYME ACTIVITY; ENZYME INHIBITION; ENZYME SUBSTRATE COMPLEX; ESCHERICHIA COLI; IC 50; INHIBITION KINETICS; MOLECULAR DOCKING; NONHUMAN; PHAGE DISPLAY; PROTEIN MOTIF;

ALCOHOL OXIDOREDUCTASES; AMINO ACID SEQUENCE; BASE SEQUENCE; CATALYTIC DOMAIN; CINNAMATES; DNA PRIMERS; ENZYME INHIBITORS; ENZYME-LINKED IMMUNOSORBENT ASSAY; ESCHERICHIA COLI; MAGNETIC RESONANCE SPECTROSCOPY; MODELS, MOLECULAR; MOLECULAR SEQUENCE DATA; PEPTIDES; SPECTROMETRY, MASS, ELECTROSPRAY IONIZATION;

BACTERIA (MICROORGANISMS); ESCHERICHIA COLI; PROKARYOTA;

EID: 59049103442     PISSN: 00092797     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.cbi.2008.09.030     Document Type: Article

References (29)

1. Zhang Y.-M., and Rock C.O. Evaluation of epigallocatechin gallate and related plant polyphenols as inhibitors of the FabG and FabI reductases of bacterial type II fatty-acid synthase. J. Biol. Chem. 279 (2004) 30994-31001
2. Price A.C., Zhang Y.-M., Rock C.O., and White S.W. Cofactor-induced conformational rearrangements establish a catalytically competent active site and a proton relay conduit in FabG. Structure 12 (2004) 417-428
3. Penning T.M. Molecular endocrinology of hydroxysteroid dehydrogenases. Endocrinol. Rev. 18 (1997) 281-305
4. Oppermann U., Kavanagh K., Guo K., Ng S., Lukacik P., Wu X., Dubinina E., Shafqat N., Bray J., Marsden B., Sujata S., Vedadi M., von Delft F., and Sundstorn M. SDR goes SGC: a structural genomics initiative. In: Weiner E., Plapp B., Lindahl R., and Maser E. (Eds). Enzymology and Molecular Biology of Carbonyl Metabolism 12 (2006), Purdue University Press 235-241
5. Krozowski Z. 11β-hydroxysteroid dehydrogenase and the short-chain alcohol dehydrogenase (SCAD) superfamily. Mol. Cell. Endocrinol. 84 (1992) C25-C31
6. Krozowski Z. The short-chain alcohol dehydrogenase superfamily: variations on a common theme. J. Steroid Biochem. Mol. Biol. 51 (1994) 125-130
7. Oppermann U.C., Filling C., Berndt K.D., Persson B., Benach J., Ladenstein R., and Jornvall H. Active-site-directed mutagenesis of 3β/17β-hydroxysteroid dehydrogenase establishes differential effects on short-chain dehydrogenase/reductase reaction. Biochemistry 36 (1997) 34-40
8. Tanabe T., Tanaka N., Uchikawa K., Kabashima T., Ito K., Nonaka T., Mitsui Y., Tsuru M., and Yoshimoto T. Roles of the Ser146, Tyr159 and Lys163 residues in the catalytic action of 7α-hydroxysteroid dehydrogenase from Escherichia coli. J. Biochem. 124 (1998) 634-641
9. Price A.C., Zhang Y.-M., Rock C.O., and White S.W. Structure of β-Ketoacyl-[acyl carrier protein] reductase from Escherichia coli: negative cooperativity and its structural basis. Biochemistry 40 (2001) 12772-12781
10. Tasdemir D., Lack G., Brun R., Rüedi P., Scapozza L., and Perozzo R. Inhibition of Plasmodium falciparum fatty acid biosynthesis: evaluation of FabG, FabZ, and FabI as drug targets for flavonoids. J. Med. Chem. 49 (2006) 3345-3353
11. Shoichet B.K. Screening in a spirit-haunted world. Drug Discov. Today 13/14 (2006) 607-615
12. Gobec S., Sova M., Kristan K., and Lanišnik Rižner T. Cinnamic acid esters as potent inhibitors of fungal 17b-hydroxysteroid dehydrogenase-a model enzyme of the short chain-dehydroganse/ reductase superfamily. Bio. Med. Chem. Lett. 14 (2004) 3933-3936
13. Kristan K., Starčević S., Brunskole M., Lanišnik Rižner T., and Gobec S. Cinnamates and cinnamamides inhibit fungal 17beta-hydroxysteroid dehydrogenase. Mol. Cell. Endocrinol. 248 (2006) 239-241
14. Sova M., Perdih A., Kotnik M., Kristan K., Lanišnik Rižner T., Šolmajer T., and Gobec S. Flavonoids and cinnamic acid esters as inhibitors of fungal 17beta-hydroxysteroid dehydrogenase: a synthesis, QSAR and modelling study. Bioorg. Med. Chem. 14 (2006) 7404-7418
15. Greene T.W., and Wuts P.G.M. Protective Groups in Organic Synthesis. 2nd ed. (1991), John Wiley and Sons, New York
16. Kocienski P.J. Protecting Groups (1994), Georg Thieme, Stuttgart
17. Castro B., Evin G., Selve C., and Seyer R. Synthesis-Stuttgart 6 (1977) 413
18. Živec M., Sova M., Brunskole M., Lenaršič R., Lanišmik Rižner T., and Gobec S. New inhibitors of fungal 17β-hydroxysteroid dehydrogenase based on the [1,5]-benzodiazepine scaffold. J. Enzym. Inhib. Med. Chem. 22 (2007) 30
19. Sova M., Perdih A., Kotnik M., Kristan K., Lanišnik Rižner T., Solmajer T., and Gobec S. Flavonoids and cinnamic acid esters as inhibitors of fungal 17β-hydroxysteroid dehydrogenase: a synthesis, QSAR and modelling study. Bioorg. Med. Chem. 14 (2006) 7404-7418
20. Barton D.H.R., and Jones D.W. Autoxidation in basic media. Part IV. Hydrocarbon autoxidation. J. Chem. Soc. (1965) 3563-3570
21. Katritzky R.A., Zhang S., Soares A., and Wang M. A facile synthesis of benzyl α, β-unsaturated carboxylic esters. ARKIVOC x (2001) 54-57
22. Bender M.L., Schonbaum G.R., and Zerner B. Spectrophotometric investigations of the mechanism of α-chymotrypsin-catalyzed hydrolyses. Detection of the acyl-enzyme intermediate. J. Am. Chem. Soc. 84 (1962) 2540-2550
23. Rarey M., Kramer B., Lengauer T., and Klebe G.A. A fast flexible docking method using an incremental construction algorithm. J. Mol. Biol. 261 (1996) 470-489
24. Heath R.J., and Rock C.O. Enoyl-acyl carrier protein reductase (fabI) plays a determinant role in completing cycles of fatty-acid elongation in Escherichia coli. J. Biol. Chem. 44 (1995) 26538-26542
25. Phage Display Websites: http://www.biosci.missouri.edu/smithgp/PhageDisplayWebsite/AmplifyingLibrary.doc, http://www.biosci.missouri.edu/smithgp/PhageDisplayWebsite/VirionPurification.doc, http://www.biosci.missouri.edu/smithgp/PhageDisplayWebsite/AffinitySelection.doc.
26. Sun Y.-H., Cheng Q., Tian W.-X., and Wu X.-D. A substitutive substrate for measurements of β-ketoacyl reductases in two fatty-acid synthase systems. J. Biochem. Biophys. Methods 70 (2008) 850-856
27. Stahl M. Modifications of the scoring function in FlexX for virtual screening applications. Perspect. Drug Discov. Des. 20 (2000) 83-98
28. Grøn H., and Hyde-DeRuyscher R. Peptides as tools in drug discovery. Curr. Opin. Drug Discov. Dev. 3 (2000) 636-645
29. Smith G.P., and Petrenko V.A. Phage display. Chem. Biol. 97 (1997) 391-410